Physician profile
Peng Yu
NPI 1124468277
$17,444.05
in general payments reported to CMS, 2019-2025
9 companies · $17K in 2025
The $17K reported for 2025 was more than what 97% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $312 · 2023: $29.00 · 2024: $251 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Food and Beverage: $382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,750.00 |
| Food and Beverage | $382.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $16,750.00 | 2025 | |
| W. L. Gore & Associates, INC. | $312.00 | 2022 | |
| Inari Medical, INC. | $122.22 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Angiodynamics, INC. | $101.61 | 2025 | Auryon Laser System 100-120 Vac |
| Mimedx Group, INC. | $46.27 | 2024 | |
| Smith+Nephew, INC. | $36.90 | 2024 | Pico 7, Pico 14 |
| Exact Sciences Corporation | $29.53 | 2024 | Cologuard Collection Kit |
| Medtronic, INC. | $29.00 | 2023 | Progrip |
| Tela Bio, INC. | $16.52 | 2024 | Ovitex 2s |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peng Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.